A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

doi:10.1001/jamainternmed.2019.6770

. 2020 Apr 1;180(4):592-595.

doi: 10.1001/jamainternmed.2019.6770.

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

Ashleigh C King¹, Lisa M Schwartz¹, Steven Woloshin^{1

2}

Affiliations

¹ The Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
² The Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont.

PMID: 31985742
PMCID: PMC6990750
DOI: 10.1001/jamainternmed.2019.6770

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

Ashleigh C King et al. JAMA Intern Med. 2020.

. 2020 Apr 1;180(4):592-595.

doi: 10.1001/jamainternmed.2019.6770.

Authors

Ashleigh C King¹, Lisa M Schwartz¹, Steven Woloshin^{1

2}

Affiliations

¹ The Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
² The Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont.

PMID: 31985742
PMCID: PMC6990750
DOI: 10.1001/jamainternmed.2019.6770

Abstract

This study describes the number and type of clinical offices receiving detailing visits and free drug samples from pharmaceutical companies.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Drs Woloshin and Schwartz receiving personal fees from Ross Feller Case LLP for serving as medical experts in testosterone litigation and are cofounders of Informulary Inc, a company that provided data about the benefits and harms of prescription drugs and ceased operations in December 2016. Ms King reported grants from Agency for Healthcare Research and Quality during the conduct of the study. No further disclosures were reported.

Figures

See this image and copyright information in PMC

Comment in

The Cost of Pharmaceutical Company Detailing Visits and Medication Samples.
Guglielmo BJ. Guglielmo BJ. JAMA Intern Med. 2020 Apr 1;180(4):595-596. doi: 10.1001/jamainternmed.2019.6761. JAMA Intern Med. 2020. PMID: 31985770 No abstract available.

Cited by

"Beyond Just a Supplement": Administrators' Visions for the Future of Virtual Primary Care Services.
Fraze TK, Beidler LB, De Marchis EH, Gottlieb LM, Potter MB. Fraze TK, et al. J Am Board Fam Med. 2022 May-Jun;35(3):527-536. doi: 10.3122/jabfm.2022.03.210479. J Am Board Fam Med. 2022. PMID: 35641035 Free PMC article.
"It's Not Just the Right Thing . . . It's a Survival Tactic": Disentangling Leaders' Motivations and Worries on Social Care.
Fraze TK, Beidler LB, Savitz LA. Fraze TK, et al. Med Care Res Rev. 2022 Oct;79(5):701-716. doi: 10.1177/10775587211057673. Epub 2021 Dec 14. Med Care Res Rev. 2022. PMID: 34906013 Free PMC article.
Resource Brokering: Efforts to Assist Patients With Housing, Transportation, and Economic Needs in Primary Care Settings.
Fraze TK, Beidler LB, Fichtenberg C, Brewster AL, Gottlieb LM. Fraze TK, et al. Ann Fam Med. 2021 Nov-Dec;19(6):507-514. doi: 10.1370/afm.2739. Ann Fam Med. 2021. PMID: 34750125 Free PMC article.
Avoiding Medicaid: Characteristics Of Primary Care Practices With No Medicaid Revenue.
Spivack SB, Murray GF, Rodriguez HP, Lewis VA. Spivack SB, et al. Health Aff (Millwood). 2021 Jan;40(1):98-104. doi: 10.1377/hlthaff.2020.00100. Health Aff (Millwood). 2021. PMID: 33400572 Free PMC article.

References

1. Schwartz LM, Woloshin S. Medical marketing in the United States, 1997-2016. JAMA. 2019;321(1):80-96. doi:10.1001/jama.2018.19320 - DOI - PubMed
1. Brax H, Fadlallah R, Al-Khaled L, et al. . Association between physicians’ interaction with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0175493. doi:10.1371/journal.pone.0175493 - DOI - PMC - PubMed
1. Larkin I, Ang D, Avorn J, Kesselheim AS. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Health Aff (Millwood). 2014;33(6):1014-1023. doi:10.1377/hlthaff.2013.0939 - DOI - PubMed
1. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750. doi:10.1056/NEJMsa064508 - DOI - PubMed
1. Dartmouth Atlas Project Map: price-adjusted total Medicare reimbursements per enrollee (parts A and B), by HRR (2016). https://www.dartmouthatlas.org/interactive-apps/medicare-reimbursements/. Accessed September 19, 2019.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

U19 HS024075/HS/AHRQ HHS/United States

LinkOut - more resources

Full Text Sources

[1] Schwartz LM, Woloshin S. Medical marketing in the United States, 1997-2016. JAMA. 2019;321(1):80-96. doi:10.1001/jama.2018.19320 - DOI - PubMed

[2] Schwartz LM, Woloshin S. Medical marketing in the United States, 1997-2016. JAMA. 2019;321(1):80-96. doi:10.1001/jama.2018.19320 - DOI - PubMed

[3] Brax H, Fadlallah R, Al-Khaled L, et al. . Association between physicians’ interaction with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0175493. doi:10.1371/journal.pone.0175493 - DOI - PMC - PubMed

[4] Brax H, Fadlallah R, Al-Khaled L, et al. . Association between physicians’ interaction with pharmaceutical companies and their clinical practices: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0175493. doi:10.1371/journal.pone.0175493 - DOI - PMC - PubMed

[5] Larkin I, Ang D, Avorn J, Kesselheim AS. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Health Aff (Millwood). 2014;33(6):1014-1023. doi:10.1377/hlthaff.2013.0939 - DOI - PubMed

[6] Larkin I, Ang D, Avorn J, Kesselheim AS. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Health Aff (Millwood). 2014;33(6):1014-1023. doi:10.1377/hlthaff.2013.0939 - DOI - PubMed

[7] Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750. doi:10.1056/NEJMsa064508 - DOI - PubMed

[8] Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750. doi:10.1056/NEJMsa064508 - DOI - PubMed

[9] Dartmouth Atlas Project Map: price-adjusted total Medicare reimbursements per enrollee (parts A and B), by HRR (2016). https://www.dartmouthatlas.org/interactive-apps/medicare-reimbursements/. Accessed September 19, 2019.

[10] Dartmouth Atlas Project Map: price-adjusted total Medicare reimbursements per enrollee (parts A and B), by HRR (2016). https://www.dartmouthatlas.org/interactive-apps/medicare-reimbursements/. Accessed September 19, 2019.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

Affiliations

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources